[1]
S. G. Fatihoglu and A. Oto, “Angiotensin Receptor Neprilysin Inhibition in Heart Failure: Clinical Benefits and Antiarrhythmic Actions”, Adv. Card. Res., vol. 2, no. 1, pp. 12–25, May 2024.